Zenas BioPharma Inc. Common Stock (NASDAQ: ZBIO)
54 Days left to seek lead plaintiff status.
The Complaint alleges that the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, Defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.